ES2174548T3 - Liposomas que contienen construcciones de peptidos con multiples ramificaciones para uso contra el virus de inmunodeficiencia humana. - Google Patents

Liposomas que contienen construcciones de peptidos con multiples ramificaciones para uso contra el virus de inmunodeficiencia humana.

Info

Publication number
ES2174548T3
ES2174548T3 ES98966710T ES98966710T ES2174548T3 ES 2174548 T3 ES2174548 T3 ES 2174548T3 ES 98966710 T ES98966710 T ES 98966710T ES 98966710 T ES98966710 T ES 98966710T ES 2174548 T3 ES2174548 T3 ES 2174548T3
Authority
ES
Spain
Prior art keywords
human immunodeficiency
against human
liposomes containing
containing peptide
use against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98966710T
Other languages
English (en)
Inventor
Rouge Bonabes-Olivier De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cellpep SA
Original Assignee
Cellpep SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellpep SA filed Critical Cellpep SA
Application granted granted Critical
Publication of ES2174548T3 publication Critical patent/ES2174548T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • AIDS & HIV (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Liposomas que tengan un tamaño suficiente para la internalización por los glóbulos blancos, de modo que los liposomas contengan una construcción de péptidos con múltiples ramificaciones que sea útil para el tratamiento de la HIV.
ES98966710T 1997-12-31 1998-12-28 Liposomas que contienen construcciones de peptidos con multiples ramificaciones para uso contra el virus de inmunodeficiencia humana. Expired - Lifetime ES2174548T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9727424.5A GB9727424D0 (en) 1997-12-31 1997-12-31 Liposomes containing multiple branch peptide constructions for use against human immunodeficiency virus

Publications (1)

Publication Number Publication Date
ES2174548T3 true ES2174548T3 (es) 2002-11-01

Family

ID=10824280

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98966710T Expired - Lifetime ES2174548T3 (es) 1997-12-31 1998-12-28 Liposomas que contienen construcciones de peptidos con multiples ramificaciones para uso contra el virus de inmunodeficiencia humana.

Country Status (13)

Country Link
US (1) US6610304B1 (es)
EP (1) EP1043974B1 (es)
JP (1) JP2002500175A (es)
AT (1) ATE215361T1 (es)
CA (1) CA2317107C (es)
DE (1) DE69804674T2 (es)
DK (1) DK1043974T3 (es)
ES (1) ES2174548T3 (es)
GB (1) GB9727424D0 (es)
HU (1) HU224715B1 (es)
PT (1) PT1043974E (es)
WO (1) WO1999034777A1 (es)
ZA (1) ZA9811877B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9727424D0 (en) * 1997-12-31 1998-02-25 Armel Sa Liposomes containing multiple branch peptide constructions for use against human immunodeficiency virus
US7285621B2 (en) * 1999-06-29 2007-10-23 Ambrilia Biopharma Multiple branch peptide construction
AU2004240765B2 (en) * 2003-05-20 2009-03-19 Cellpep Sa Modified antiviral peptides with increased activity and cell membrane affinity
US7676835B2 (en) * 2004-08-31 2010-03-09 International Business Machines Corporation System and method for regulating access to objects in a content repository
WO2010135714A2 (en) 2009-05-22 2010-11-25 The Methodist Hospital Research Institute Methods for modulating adipocyte expression using microrna compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5709879A (en) * 1990-06-29 1998-01-20 Chiron Corporation Vaccine compositions containing liposomes
IL110929A0 (en) * 1993-09-13 1994-11-28 Armel Sa Multiple branch peptide constructions and pharmaceutical compositions containing them
GB9627114D0 (en) * 1996-12-31 1997-02-19 Centre Nat Rech Scient Multiple branch peptide constructions
GB9727424D0 (en) * 1997-12-31 1998-02-25 Armel Sa Liposomes containing multiple branch peptide constructions for use against human immunodeficiency virus

Also Published As

Publication number Publication date
US6610304B1 (en) 2003-08-26
ZA9811877B (en) 1999-08-05
EP1043974A1 (en) 2000-10-18
CA2317107C (en) 2008-03-11
EP1043974B1 (en) 2002-04-03
PT1043974E (pt) 2002-09-30
HU224715B1 (en) 2006-01-30
HUP0100937A3 (en) 2004-06-28
ATE215361T1 (de) 2002-04-15
WO1999034777A1 (en) 1999-07-15
CA2317107A1 (en) 1999-07-15
DE69804674T2 (de) 2002-10-31
DE69804674D1 (de) 2002-05-08
HUP0100937A2 (hu) 2001-06-28
GB9727424D0 (en) 1998-02-25
JP2002500175A (ja) 2002-01-08
DK1043974T3 (da) 2002-07-15

Similar Documents

Publication Publication Date Title
ES2032802T3 (es) Sucedaneo de la sangre, semisintetico, extrapuro.
ES2182837T3 (es) Piran-2-onas y 5,6-dihidropiran-2-onas utiles en el tratamiento del sida y de otros retrovirus.
ES2192201T3 (es) Compuestos de piranona utiles para el tratamiento de infecciones retrovirales.
ES2188783T3 (es) Empleo de una tienotriazolodiazepina para aumentar los niveles de apolipoproteina a-i.
MX9307686A (es) Preparacion de liberacion sostenida.
ES2134764T3 (es) Inhibidores de hiv proteasa.
ES8705764A1 (es) Procedimiento fotodinamico de inactivacion de virus
DK0850046T3 (da) Mikroemulsioner til anvendelse som vhikel til indgift af active forbindelser
ES2143558T3 (es) Agentes policiclicos antiparasitarios, procedimiento y cepa para su preparacion y su uso.
CL2008003938A1 (es) Uso de escitalopram o de una sal farmaceuticamente aceptable del mismo para preparar un medicamento util en el tratamiento del desorden de estres postraumatico (divisional sol. 1799-00).
ES2134197T3 (es) Vacunas contra el virus del herpes simplex vp16.
MX9203972A (es) Compuestos inhibidores de la proteasa codificada por el virus de la inmunodeficiencia humana, procedimiento para su preparacion y formulado farmaceutico que los contiene.
MX9301136A (es) Composiciones que contienen psyllium.
ES2038650T3 (es) Procedimiento para preparar una composicion farmaceutica que comprende 3'-desoxitimidin-2'-eno-(3'-desoxi-2',3'-dideshidrotimidina) para tratar pacientes infectados con retrovirus.
ES2107033T3 (es) Peptidos bpc, su preparacion y su utilizacion.
PA8451701A1 (es) Formulacion inyectable transparente de compuesto anestesico
ES2081491T3 (es) Nuevo polipeptido y farmaco anti-vih preparado a partir de este polipeptido.
DK0792165T3 (da) Immunogene præparater
ES2174548T3 (es) Liposomas que contienen construcciones de peptidos con multiples ramificaciones para uso contra el virus de inmunodeficiencia humana.
EA200100540A1 (ru) Фармацевтическая композиция с модифицированным высвобождением сенсибилизатора к инсулину
ES2100689T3 (es) Asociacion sinergizante que tiene un efecto antagonista de los receptores nk1 y nk2.
ES2166900T3 (es) Derivados de ara-c.
ES2118386T3 (es) Procedimiento para la inactivacion de virus que no estan provistos de envolventes lipidicas.
ES2103577T3 (es) Compuestos antiviricos de naftoquinona, composiciones que los contienen y utilizaciones de estos compuestos.
SV1997000090A (es) Composiciones farmaceuticas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 1043974

Country of ref document: ES